Ono type DX Breast Recurrence Score Test
awardedLeeds Teaching Hospitals NHS Trust · GB-CFS-229255
Read the notice at Contracts Finder ↗
Value
£338k
Published
26 Oct 2026
Deadline
30 Jun 2026, 12:00 BST
Type
award · framework
85111800 · Health & social work servicesYorkshire & the Humber
Description
Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.
Key facts
- Reference
- CF-3741100D0O000000rwimUAA
- Procedure
- Call-off from a framework agreement
- Framework agreement
- Yes — a framework or dynamic purchasing system, not a single contract
- Contact
- Lorraine Byronlorraine.byron@nhs.net
- Contract period
- 1 Jul 2026 → 30 Jun 2028
- Category
- goods
Awarded suppliers
- Exact Sciences UK, Ltd. · GB-CFS-181443
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- Contracts Finder
- Notice id
- 8c60ade2-e308-4405-8dd6-657c132b1cb3-919091
- OCID
- ocds-b5fd17-3205757c-a10d-4c89-8861-ac69b727b6c4
- First seen
- 26 Oct 2026
- Last updated
- 26 Oct 2026
Licence Open Government Licence v3.0 ↗
Contains public sector information licensed under the Open Government Licence v3.0. Source: Contracts Finder.
View at source ↗
GET /api/v1/tenders/1028b5f5-8ce9-454b-a6ac-599c8b3b92ccThe source notice is authoritative — verify deadlines and documents there before bidding.